Legal Representation
Attorney
Philip Y. Braginsky
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 12, 2018 | UNDN | O | UNDELIVERABLE MAIL - NO ACTION TAKEN | Loading... |
| Dec 14, 2017 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 14, 2017 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 18, 2017 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 18, 2017 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 18, 2017 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 17, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 27, 2017 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 26, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 25, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 25, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 18, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 26, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 26, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 26, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 19, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 5, 2016 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 5, 2016 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 16, 2016 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Jul 15, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 14, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Synthetic biological tissue cultures for medical purposes; Synthetic biological tissue grafts; Synthetic biological in-vitro made human, animal and plant tissue intended for subsequent implantation; Synthetic biological in-vitro human tissues made to the advantage of patients, eliminating rejection of the transplanted tissue intended for subsequent implantation; Synthetic biological in-vitro tissue used for the healing of burned wounds, and on muscle, cartilage, tendons, bone and internal organs namely, liver, kidney and other organs resulting in Synthetic tissue intended for subsequent implantation
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
THREE DIMENSIONAL CELL BIOLOGICAL PRINTING
Classification
International Classes
005